Stand Robot and Haier Biotech reached a comprehensive strategic cooperation

On November 26th, Stand Robotics and Qingdao Haier Biomedical Co., Ltd. (hereinafter referred to as “Haier Biomedical”) signed a strategic cooperation agreement. The two parties will carry out comprehensive and multi-level development in key areas such as the popularization and application of robots in smart medical scenarios. , In-depth cooperation in a wide range of fields.

STAND Robotics is an industry-leading industrial-grade mobile robot R&D and production company. As a leader in the AMR industry, it has achieved full coverage of independent research and development of core technologies such as robot positioning and navigation algorithms, operation scheduling systems, and controllers. The products have been applied in China and the United States. , Japan, Europe, Middle East, Southeast Asia and other countries and regions, and serve many industries such as 3C, medical and pharmaceutical, semiconductor, photovoltaic, lithium battery, panel, automobile and auto parts.

Haier Biotechnology is the world’s leading provider of integrated biosafety solutions for the Internet of Things. Its innovative biomedical scenarios have been applied to more than 120 countries and regions around the world, covering tens of thousands of domestic hospitals, biotechnology companies, university scientific research institutions, and disease control , Plasma stations, testing institutions and other medical and health end users.

In this strategic cooperation, Haier Biosciences has introduced STAND’s robotic artificial intelligence technology into its blood component preparation, drug management and other scenarios to promote the popularization and application of robots in smart medical scenarios and accelerate the digitization of biosafety digital medical solutions for the Internet of Things. Modernization and convenience upgrade.

Wang Yongkun, CEO of STAND Robotics, said: “The integration of STAND Robots into Haier Bio’s smart medical scene will bring safer, more accurate and efficient scene solutions to the medical field, and will strongly promote the digitalization of my country’s medical scene management.”

Chen Haitao, deputy general manager of Haier Biology, said: “Stander Robotics and Haier Biology will use their respective technical advantages to accelerate the development of intelligent, digital, and unmanned urban blood management and drug management, and achieve cost reduction and efficiency enhancement at the same time. Promote new infrastructure for digital healthcare.”

Standing at the new starting point of the 14th Five-Year Plan, from “manufacturing” to “intelligent manufacturing”, it is imperative to upgrade the medical industry. As leaders in their respective fields, the two parties have strong complementary advantages and a good foundation for cooperation. The comprehensive strategic cooperation will also add new impetus to the construction of the whole healthy China by STAND Robots. In the future, the two parties will continue to expand the depth and breadth of cooperation and jointly create high-quality intelligent medical services.

The Links:   FF100R12RT4 LM215WF3-SLC2

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *